Ads

 

Ads

 

Ads

 

World Top 100 HealthCare Products Companies List by Market Cap as of August 2026

World Top 100 HealthCare Products Companies List by Market Cap as of August 2026, World Biggest 100 HealthCare Products Companies by Market Cap, World Largest 100 HealthCare Products Companies in the World by market cap as of August 2026.

Metatag Title
World Largest HealthCare Products Companies in 2026
Metatag Abstract
World Top HealthCare Products Companies by Market Cap in 2026, World Largest HealthCare Products Companies by Market Cap in 2026.
  1. Magellan Health

    World Rank (Aug-2026)
    5,480
    World Rank (Jan-05-2024)
    5,480
    World Rank (Jul-30-2023)
    5,480
    World Rank (Dec-25-2022)
    5,480
    World Rank (Jan-07-2022)
    5,480
    Market Cap (Jan-07-2022)
    2.50 Billion USD
    Annual Revenue in USD
    4,578 Million USD
    Annual Net Income in USD
    382 Million USD
    Annual Results for Period Ending
    For year ending December-2020
    Headquarters Country
    Company Profile

    Magellan Health is a leader in managing complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan’s customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. The headquarters is in USA.

  2. Kobayashi Pharmaceutical

    World Rank (Aug-2026)
    5,530
    Market Cap (Aug-2026)
    2.559 Billion USD
    World Rank (Jan-05-2024)
    3,969
    Market Cap (Jan-05-2024)
    3.401 Billion USD
    World Rank (Jul-30-2023)
    3,432
    Market Cap (Jul-30-2023)
    4.195 Billion USD
    World Rank (Dec-25-2022)
    2,775
    Market Cap (Dec-25-2022)
    4.901 Billion USD
    World Rank (Jan-07-2022)
    2,826
    Market Cap (Jan-07-2022)
    6.01 Billion USD
    Annual Revenue in USD
    1,229 Million USD
    Annual Net Income in USD
    156 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Kobayashi Pharmaceutical is a Manufacturing and sales of OTC pharmaceuticals, guasi drugs, deodorizing air fresheners and sanitary products company. It Common Stock is 3,450 million yen and employees is 4849. The headquarters is in Japan.
  3. Neogen Corporation

    World Rank (Aug-2026)
    5,559
    Market Cap (Aug-2026)
    2.540 Billion USD
    World Rank (Jan-05-2024)
    3,352
    Market Cap (Jan-05-2024)
    4.227 Billion USD
    World Rank (Jul-30-2023)
    2,981
    Market Cap (Jul-30-2023)
    4.993 Billion USD
    World Rank (Dec-25-2022)
    3,893
    Market Cap (Dec-25-2022)
    3.214 Billion USD
    World Rank (Jan-07-2022)
    3,668
    Market Cap (Jan-07-2022)
    4.31 Billion USD
    Annual Revenue in USD
    870 Million USD
    Annual Operating Income in USD
    -22 Million USD
    Annual Net Income in USD
    -8 Million USD
    Annual Results for Period Ending
    For year ending May-2026
    Headquarters Country
    Company Profile

    Neogen Corporation is a Food Processing, Animal Protein and Agriculture Industries company. It serve the companion and performance animal industries as well as the fields of life sciences and toxicology. The headquarters is in USA.

  4. Hutchison China Meditech

    World Rank (Aug-2026)
    5,578
    Market Cap (Aug-2026)
    2.522 Billion USD
    World Rank (Jan-05-2024)
    4,263
    Market Cap (Jan-05-2024)
    3.110 Billion USD
    World Rank (Jul-30-2023)
    4,768
    Market Cap (Jul-30-2023)
    2.625 Billion USD
    World Rank (Dec-25-2022)
    4,511
    Market Cap (Dec-25-2022)
    2.635 Billion USD
    World Rank (Jan-07-2022)
    2,820
    Market Cap (Jan-07-2022)
    6.03 Billion USD
    Annual Revenue in USD
    356 Million USD
    Annual Net Income in USD
    -194 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Hutchison China Meditech is an innovative, commercial stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The headquarters is in Hong Kong.

  5. BioCryst Pharmaceuticals

    World Rank (Aug-2026)
    5,615
    Market Cap (Aug-2026)
    2.489 Billion USD
    World Rank (Jan-05-2024)
    7,310
    Market Cap (Jan-05-2024)
    1.323 Billion USD
    World Rank (Jul-30-2023)
    7,021
    Market Cap (Jul-30-2023)
    1.451 Billion USD
    World Rank (Dec-25-2022)
    5,228
    Market Cap (Dec-25-2022)
    2.135 Billion USD
    World Rank (Jan-07-2022)
    6,134
    Market Cap (Jan-07-2022)
    2.08 Billion USD
    Annual Revenue in USD
    875 Million USD
    Annual Operating Income in USD
    341 Million USD
    Annual Net Income in USD
    264 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    BioCryst Pharmaceuticals is a Biotechnology company designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP). The company annual revenue is 49 million USD and 140 employees as on 2019. The headquarters is in USA.
  6. Nektar Therapeutics

    World Rank (Aug-2026)
    5,639
    Market Cap (Aug-2026)
    2.467 Billion USD
    World Rank (Jan-05-2024)
    21,027
    Market Cap (Jan-05-2024)
    0.108 Billion USD
    World Rank (Jul-30-2023)
    21,502
    Market Cap (Jul-30-2023)
    0.103 Billion USD
    World Rank (Dec-25-2022)
    13,797
    Market Cap (Dec-25-2022)
    0.404 Billion USD
    World Rank (Jan-07-2022)
    5,673
    Market Cap (Jan-07-2022)
    2.34 Billion USD
    Annual Revenue in USD
    55 Million USD
    Annual Operating Income in USD
    -140 Million USD
    Annual Net Income in USD
    -164 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Nektar Therapeutics is a research based development stage Biopharmaceutical company. It R&D pipeline of new investigational drugs includes treatments for cancer and auto immune disease and leverage Nektar's proprietary and proven chemistry platform in the discovery and design of new drug candidates. The headquarters is in USA.
  7. Yipinhong Pharmaceutical

    World Rank (Aug-2026)
    5,658
    Market Cap (Aug-2026)
    2.452 Billion USD
    World Rank (Jan-05-2024)
    5,991
    Market Cap (Jan-05-2024)
    1.838 Billion USD
    World Rank (Jul-30-2023)
    6,307
    Market Cap (Jul-30-2023)
    1.721 Billion USD
    World Rank (Dec-25-2022)
    7,017
    Market Cap (Dec-25-2022)
    1.351 Billion USD
    World Rank (Jan-07-2022)
    7,265
    Market Cap (Jan-07-2022)
    1.57 Billion USD
    Headquarters Country
  8. Shandong Buchang Pharmaceuticals

    World Rank (Aug-2026)
    5,672
    Market Cap (Aug-2026)
    2.436 Billion USD
    World Rank (Jan-05-2024)
    4,791
    Market Cap (Jan-05-2024)
    2.632 Billion USD
    World Rank (Jul-30-2023)
    4,174
    Market Cap (Jul-30-2023)
    3.183 Billion USD
    World Rank (Dec-25-2022)
    3,640
    Market Cap (Dec-25-2022)
    3.519 Billion USD
    World Rank (Jan-07-2022)
    4,123
    Market Cap (Jan-07-2022)
    3.73 Billion USD
    Annual Revenue in USD
    2,294 Million USD
    Annual Net Income in USD
    188 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Shandong Buchang Pharmaceuticals is specialized in the R&D (Research and development), production and sale of TCM (Traditional Chinese medicine) patent medicines, supplemented by many fields, i.e. hi tech industry and health industries company. It is having 7,923 employees as on 2019. The headquarters is in China.
  9. Bausch Health Companies

    World Rank (Aug-2026)
    5,673
    Market Cap (Aug-2026)
    2.435 Billion USD
    World Rank (Jan-05-2024)
    4,383
    Market Cap (Jan-05-2024)
    2.995 Billion USD
    World Rank (Jul-30-2023)
    3,918
    Market Cap (Jul-30-2023)
    3.484 Billion USD
    World Rank (Dec-25-2022)
    4,972
    Market Cap (Dec-25-2022)
    2.291 Billion USD
    World Rank (Jan-07-2022)
    1,934
    Market Cap (Jan-07-2022)
    9.71 Billion USD
    Annual Revenue in USD
    8,434 Million USD
    Annual Net Income in USD
    -948 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    Bausch Health Companies is a pharmaceutical company. It engages in the development, manufacture, market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over the counter products. The headquarters is in Canada.

  10. China Resources Double-Crane Pharmaceutical

    World Rank (Aug-2026)
    5,713
    Market Cap (Aug-2026)
    2.407 Billion USD
    World Rank (Jan-05-2024)
    4,713
    Market Cap (Jan-05-2024)
    2.695 Billion USD
    World Rank (Jul-30-2023)
    4,983
    Market Cap (Jul-30-2023)
    2.472 Billion USD
    World Rank (Dec-25-2022)
    4,033
    Market Cap (Dec-25-2022)
    3.051 Billion USD
    World Rank (Jan-07-2022)
    5,979
    Market Cap (Jan-07-2022)
    2.16 Billion USD
    Annual Revenue in USD
    1,326 Million USD
    Annual Net Income in USD
    136 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country

Share

Ads